
The Changing Landscape of Drug Pricing: What Pharma Needs to Know in 2025
The landscape of drug pricing in the United States is currently undergoing a period of significant and unprecedented change, marked by potentially transformative reforms. This blog post delves into the intricacies of several key initiatives that are reshaping the pharmaceutical industry. Specifically, we will examine the Inflation Reduction Act, a landmark piece of legislation with far-reaching implications for drug costs.